Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1)

Naomi A. Fineberg; Eric Hollander; Jon E. Grant; Samuel R. Chamberlain; Lynne M. Drummond; Luca Pellegrini; Keith R. Laws; David Wellsted; Jemma Reid; Vera Nezgovorova; David S. Baldwin

doi:10.1016/j.comppsych.2022.152323

Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1)

Naomi A. Fineberg
, Eric Hollander
, Jon E. Grant
, Samuel R. Chamberlain
, Lynne M. Drummond
, Luca Pellegrini
, Keith R. Laws
, David Wellsted
, Jemma Reid
, Vera Nezgovorova
, David S. Baldwin

Psychiatry and Behavioral Sciences

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	152323
Journal	Comprehensive Psychiatry
Volume	116
DOIs	https://doi.org/10.1016/j.comppsych.2022.152323
State	Published - Jul 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Clinical Psychology
Psychiatry and Mental health

Access to Document

10.1016/j.comppsych.2022.152323

Cite this

Fineberg, N. A., Hollander, E., Grant, J. E., Chamberlain, S. R., Drummond, L. M., Pellegrini, L., Laws, K. R., Wellsted, D., Reid, J., Nezgovorova, V., & Baldwin, D. S. (2022). Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1). Comprehensive Psychiatry, 116, Article 152323. https://doi.org/10.1016/j.comppsych.2022.152323

Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1). / Fineberg, Naomi A.; Hollander, Eric; Grant, Jon E. et al.
In: Comprehensive Psychiatry, Vol. 116, 152323, 07.2022.

Research output: Contribution to journal › Letter › peer-review

Fineberg, NA, Hollander, E, Grant, JE, Chamberlain, SR, Drummond, LM, Pellegrini, L, Laws, KR, Wellsted, D, Reid, J, Nezgovorova, V & Baldwin, DS 2022, 'Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1)', Comprehensive Psychiatry, vol. 116, 152323. https://doi.org/10.1016/j.comppsych.2022.152323

Fineberg NA, Hollander E, Grant JE, Chamberlain SR, Drummond LM, Pellegrini L et al. Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1). Comprehensive Psychiatry. 2022 Jul;116:152323. doi: 10.1016/j.comppsych.2022.152323

Fineberg, Naomi A. ; Hollander, Eric ; Grant, Jon E. et al. / Commentary on the article : “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1). In: Comprehensive Psychiatry. 2022 ; Vol. 116.

@article{d4c7c9967ea4474296c080df615c41f0,

title = "Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1)",

author = "Fineberg, \{Naomi A.\} and Eric Hollander and Grant, \{Jon E.\} and Chamberlain, \{Samuel R.\} and Drummond, \{Lynne M.\} and Luca Pellegrini and Laws, \{Keith R.\} and David Wellsted and Jemma Reid and Vera Nezgovorova and Baldwin, \{David S.\}",

note = "Funding Information: Prof. Grant has received research grants from Otsuka and Biohaven Pharmaceuticals. He receives yearly compensation from Springer Publishing for acting as Editor-in-Chief of the Journal of Gambling Studies and has received royalties from Oxford University Press, American Psychiatric Publishing, Inc., Norton Press, and McGraw Hill. ",

year = "2022",

month = jul,

doi = "10.1016/j.comppsych.2022.152323",

language = "English (US)",

volume = "116",

journal = "Comprehensive Psychiatry",

issn = "0010-440X",

publisher = "W.B. Saunders",

}

TY - JOUR

T1 - Commentary on the article

T2 - “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1)

AU - Fineberg, Naomi A.

AU - Hollander, Eric

AU - Grant, Jon E.

AU - Chamberlain, Samuel R.

AU - Drummond, Lynne M.

AU - Pellegrini, Luca

AU - Laws, Keith R.

AU - Wellsted, David

AU - Reid, Jemma

AU - Nezgovorova, Vera

AU - Baldwin, David S.

N1 - Funding Information: Prof. Grant has received research grants from Otsuka and Biohaven Pharmaceuticals. He receives yearly compensation from Springer Publishing for acting as Editor-in-Chief of the Journal of Gambling Studies and has received royalties from Oxford University Press, American Psychiatric Publishing, Inc., Norton Press, and McGraw Hill.

PY - 2022/7

Y1 - 2022/7

UR - https://www.scopus.com/pages/publications/85129716419

UR - https://www.scopus.com/pages/publications/85129716419#tab=citedBy

U2 - 10.1016/j.comppsych.2022.152323

DO - 10.1016/j.comppsych.2022.152323

M3 - Letter

C2 - 35537294

AN - SCOPUS:85129716419

SN - 0010-440X

VL - 116

JO - Comprehensive Psychiatry

JF - Comprehensive Psychiatry

M1 - 152323

ER -

Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1)

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this